Abdellah Tebani
Overview
    Explore the profile of Abdellah Tebani including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              68
            
            
              Citations
              1111
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Demailly Z, Tamion F, Besnier E, Bekri S, Tebani A
  
  
    Mol Cell Endocrinol
    . 2025 Feb;
          600:112491.
    
    PMID: 39961415
  
  
          The management of shock in critical care must transition from a predominantly hemodynamic approach to one that comprehensively addresses the biological intricacies of this complex multisystemic syndrome. A thorough understanding...
      
2.
        
    
    Ducatez F, Berger M, Pilon C, Plichet T, Lesueur C, Berger J, et al.
  
  
    J Mol Med (Berl)
    . 2024 Dec;
          103(2):187-203.
    
    PMID: 39738845
  
  
          Gaucher disease (GD), an autosomal recessive lysosomal disorder, primarily affects the lysosomal enzyme β-glucocerebrosidase (GCase), leading to glucosylceramide accumulation in lysosomes. GD presents a wide spectrum of clinical manifestations. This...
      
3.
        
    
    Ducatez F, Mauhin W, Ottaviani J, Plichet T, Pilon C, Lidove O, et al.
  
  
    J Clin Lab Anal
    . 2024 Dec;
          39(1):e25131.
    
    PMID: 39727194
  
  
          Background: Sphingolipidoses are rare inherited metabolic diseases belonging to lysosomal diseases. Early and accurate diagnosis is crucial for effective management and treatment. In this study, we aimed to develop a...
      
4.
        
    
    Fontanilles M, Heisbourg J, Daban A, Di Fiore F, Pepin L, Marguet F, et al.
  
  
    Acta Neuropathol Commun
    . 2024 Oct;
          12(1):162.
    
    PMID: 39394177
  
  
          Monitoring tumor evolution and predicting survival using non-invasive liquid biopsy is an unmet need for glioblastoma patients. The era of proteomics and metabolomics blood analyzes, may help in this context....
      
5.
        
    
    Snanoudj S, Derambure C, Zhang C, Yen N, Lesueur C, Coutant S, et al.
  
  
    Heliyon
    . 2024 Aug;
          10(14):e34357.
    
    PMID: 39100494
  
  
          Fabry disease (FD) is an X-linked lysosomal disease caused by an enzyme deficiency of alpha-galactosidase A (α-gal A). This deficiency leads to the accumulation of glycosphingolipids in lysosomes, resulting in...
      
6.
        
    
    Noyan B, Elcioglu N, Tebani A, Bekri S
  
  
    Mol Syndromol
    . 2024 Jun;
          15(3):194-201.
    
    PMID: 38841321
  
  
          Introduction: Sanfilippo syndrome or mucopolysaccharidosis type 3 (MPS-3) is a rare condition and its epidemiological data are still not defined. MPS-3 is linked to a deficiency in enzymes involved in...
      
7.
        
    
    Bekri S, Bley A, Brown H, Chanson C, Church H, Gelb M, et al.
  
  
    Mol Genet Metab
    . 2024 Mar;
          142(1):108436.
    
    PMID: 38552449
  
  
          Newborn screening (NBS) for metachromatic leukodystrophy (MLD) is based on first-tier measurement of sulfatides in dried blood spots (DBS) followed by second-tier measurement of arylsulfatase A in the same DBS....
      
8.
        
    
    Jotanovic J, Tebani A, Hekmati N, Sivertsson A, Lindskog C, Uhlen M, et al.
  
  
    J Endocr Soc
    . 2024 Mar;
          8(5):bvae040.
    
    PMID: 38505563
  
  
          Although most pituitary neuroendocrine tumors (PitNETs)/pituitary adenomas remain intrasellar, a significant proportion of tumors show parasellar invasive growth and 6% to 8% infiltrate the bone structures, thus affecting the prognosis....
      
9.
        
    
    Ducatez F, Tebani A, Abily-Donval L, Snanoudj S, Pilon C, Plichet T, et al.
  
  
    Pediatr Res
    . 2024 Mar;
          96(2):395-401.
    
    PMID: 38467704
  
  
          Background: Despite advancements in neonatal care, germinal matrix-intraventricular hemorrhage impacts 20% of very preterm infants, exacerbating their neurological prognosis. Understanding its complex, multifactorial pathophysiology and rapid onset remains challenging. This...
      
10.
        
    
    Dabaj I, Ducatez F, Marret S, Bekri S, Tebani A
  
  
    Clin Chim Acta
    . 2023 Dec;
          553:117691.
    
    PMID: 38081447
  
  
          Neuromuscular disorders encompass a spectrum of conditions characterized by primary lesions within the peripheral nervous system, which include the anterior horn cell, peripheral nerve, neuromuscular junction, and muscle. In pediatrics,...